B
Byung Ho Son
Researcher at University of Ulsan
Publications - 248
Citations - 4708
Byung Ho Son is an academic researcher from University of Ulsan. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 33, co-authored 223 publications receiving 3985 citations. Previous affiliations of Byung Ho Son include Asan Medical Center & Sungkyunkwan University.
Papers
More filters
Journal ArticleDOI
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
Dong Il Park,Jung Won Yun,Jung Ho Park,Sukjoong Oh,Hong Joo Kim,Yong Kyun Cho,Chong Il Sohn,Woo Kyu Jeon,Byung Ik Kim,Chang Hak Yoo,Byung Ho Son,Eun Yoon Cho,Seoung Wan Chae,Eo Jin Kim,Jin Hee Sohn,Seungho Ryu,Antonia R. Sepulveda +16 more
TL;DR: Age, TNM stage, and amplification of HER-2/neu were found to be independently related to survival by multivariate analysis, and patients exhibiting Herceptin therapy for gastric cancer patients might constitute potential candidates for new adjuvant therapies which involve the use of humanized monoclonal antibodies.
Journal ArticleDOI
Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life.
Soo-Hyun Kim,Byung Ho Son,Sook Yeon Hwang,Wonshik Han,Jung Hyun Yang,Seeyoun Lee,Young Ho Yun +6 more
TL;DR: Both fatigue and depression were negatively associated with survivors' health-related quality of life, however, the patterns of differences in health- relatedquality of life according to severity of fatigue or depression were similar.
Journal ArticleDOI
Poor Outcome of Hormone Receptor–Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea—A Report From the Korean Breast Cancer Society
TL;DR: Younger patients (age < 35) showed worse prognosis than older patients ( age, 35 to 50 years) only in the hormone receptor-unknown or hormone receptors-positive subgroups, and adjuvant tamoxifen therapy might provide less survival benefit when added to chemotherapy in very young breast cancer patients.
Journal ArticleDOI
Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer
TL;DR: LADG with extended lymphadenectomy for AGC is a feasible and safe procedure and has several advantages, and this method can achieve a radical oncologic equivalent resection.
Journal ArticleDOI
Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study.
Hee Jeong Kim,Eun Hwa Park,Woo Sung Lim,Jin Young Seo,Beom Suk Koh,Taik Jong Lee,Jin Sup Eom,Sung Wook Lee,Byung Ho Son,Jong Won Lee,Sei Hyun Ahn +10 more
TL;DR: NASSM with immediate transverse rectus abdominis musculocutaneous reconstruction is a viable surgical treatment in breast cancer patients in any stage and recurrence and complication rates for NASSM were similar to those for standard surgical breast cancer treatments.